Recent News

Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

December 16, 2014
Not Flagship

Quanterix Announces the Simoa Accelerator, an Innovation Center for Biomarker Research and Custom Assay Development

December 16, 2014
Not Flagship

Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors

December 12, 2014
Not Flagship

Syros Pharmaceuticals Presents New Data from Its Gene Control Platform at Oncology Conferences

December 11, 2014
Not Flagship

Syros Pharmaceuticals Announces New Research Published on CDK7 in Lung and Pediatric Cancers

December 11, 2014
Not Flagship

Symbiota Appoints International Plant Sciences Leader Dr. Roger Beachy to its Board of Directors

December 10, 2014
Not Flagship

Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors

December 10, 2014
Not Flagship

Concert Pharmaceuticals Names Thomas Auchincloss to Board of Directors and Chair of the Audit Committee

December 10, 2014
Not Flagship

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update

December 9, 2014
Not Flagship

Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016

December 8, 2014
Not Flagship

Pronutria Adds Industry Leaders to its Board of Directors

December 8, 2014
Not Flagship

Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency

December 8, 2014
Not Flagship

New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition

December 8, 2014
Not Flagship

Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies

December 7, 2014
Not Flagship

New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition

December 7, 2014
Not Flagship

Pronutria Appoints Dr. Peter Mueller as President of R&D and Chief Scientific Officer

December 4, 2014
Not Flagship

Seres Health Closes $48 Million Series C Financing

December 2, 2014
Not Flagship

Broad Institute, Harvard, And MIT License CRISPR-Cas9 Technology To Editas Medicine For Therapeutic Applications

December 1, 2014
Not Flagship

Editas Medicine Licenses Genome Editing Technology from Duke University

December 1, 2014
Not Flagship

Editas Medicine Licenses Genome Editing Technology from Massachusetts General Hospital

December 1, 2014
Not Flagship

Eleven Biotherapeutics Announces Additional Financing of $20 Million

November 25, 2014
Not Flagship

TIME's Best Inventions List Also Includes an Edible Invention from Cambridge

November 24, 2014
Not Flagship

BIND Therapeutics Presents Positive Phase 2 Results Highlighting Potential of BIND-014 as Novel Anti-Cancer Treatment at Q3W Dosing Schedule for Patients with Non-small Cell Lung Cancer at 26th EORTC-NCI-AACR Annual Symposium

November 19, 2014
Not Flagship

Black Duck Software Appoints Global Sales Veteran Adam Clay as Vice President of Worldwide Sales

November 18, 2014
Not Flagship

Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)

November 18, 2014
Not Flagship

Seres Health Appoints Biotechnology Finance Leader Eric Shaff as Chief Financial Officer

November 17, 2014
Not Flagship

Eleven Biotherapeutics Reports Third Quarter 2014 Financial Results

November 13, 2014
Not Flagship

Flagship VentureLabs™ Introduces Symbiota, Pioneer of Agricultural Innovation Through the Plant Microbiome

November 13, 2014
Not Flagship

Joule Names Industry Veteran Serge Tchuruk as President and CEO

November 13, 2014
Not Flagship

Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program

November 12, 2014
Not Flagship

Avedro Granted Korean Approval for its KXL® Cross-Linking System for Lasik Xtra®

November 7, 2014
Not Flagship

Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results

November 7, 2014
Not Flagship

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results

November 7, 2014
Not Flagship

BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology

November 6, 2014
Not Flagship

BIND Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update

November 6, 2014
Not Flagship

Syros Pharmaceuticals’ Scientists Publish New Method to Detect Epigenomic Changes Following Drug Treatment

November 6, 2014
Not Flagship

BIND Therapeutics Appoints Hagop Youssoufian, M.Sc., M.D. as Chief Medical Officer

November 4, 2014
Not Flagship

Mascoma Completes the Sale of its Yeast Business to Lallemand Inc.

November 4, 2014
Not Flagship

T2 Biosystems Reports 2014 Third Quarter Highlights and Financial Results

November 4, 2014
Not Flagship

Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease

November 3, 2014
Not Flagship

Visterra Announces Additions to its Management Team and Board of Directors

October 31, 2014
Not Flagship

Nielsen Acquires Affinnova

October 30, 2014
Not Flagship

Syros Pharmaceuticals Closes $53 Million Series B Financing

October 27, 2014
Not Flagship

Novomer Announces First Commercial Adoption of Converge® Polyols for Polyurethane Adhesives

October 27, 2014
Not Flagship

The TransMedics® Organ Care System (OCS™) Heart Technology Was Used to Perform The World’s First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent’s Hospital in Sydney, Australia

October 24, 2014
Not Flagship

Eleven Biotherapeutics Appoints Wendy L. Dixon, PhD to Board of Directors

October 23, 2014
Not Flagship

Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation

October 21, 2014
Not Flagship

Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics™

October 16, 2014
Not Flagship

Selecta, JDRF and Sanofi Extend Collaboration to Develop a Synthetic Vaccine Particle Immunotherapy for Type 1 Diabetes

October 15, 2014
Not Flagship

Selecta Announces More than $20 Million in Equity Funding

October 15, 2014
Not Flagship

Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221

October 15, 2014
Not Flagship

Syros Pharmaceuticals’ Scientific Founders Publish New Research on Gene Control Mechanisms

October 14, 2014
Not Flagship

Acceleron Initiates Phase 1 Clinical Trial with Innovative Muscle Drug ACE-083

October 14, 2014
Not Flagship

Concert Pharmaceuticals Presents Positive Data from Multiple Dose Phase 1 Clinical Trial of CTP-354, Lead Candidate for the Treatment of Spasticity

October 13, 2014
Not Flagship

Oasys Water Named to the 2014 Global Cleantech 100

October 7, 2014
Not Flagship

Eleven Biotherapeutics Granted U.S. Composition-of-Matter Patent for EBI-005

October 7, 2014
Not Flagship

Seres Health Appoints Two New Board Members

October 6, 2014
Not Flagship

Eleven Biotherapeutics Announces Top-Line Results from Phase 2 Study of EBI-005 in Patients with Moderate to Severe Allergic Conjunctivitis

October 2, 2014
Not Flagship

Visterra Closes $30 Million Series B Financing to Advance Pipeline of Multiple Products for Infectious Diseases

October 2, 2014
Not Flagship

Avedro Announces Resubmission of New Drug Application to FDA for Corneal Cross-Linking

September 30, 2014
Not Flagship

Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014

September 26, 2014
Not Flagship

Syros Pharmaceuticals Presents Research on Gene Control in Acute Myeloid Leukemia at AACR Hematologic Malignancies Meeting

September 23, 2014
Not Flagship

FierceBiotech names Editas Medicine as one of its “Fierce 15” Biotech Companies of 2014

September 22, 2014
Not Flagship

Seres Health Named a "Fierce 15" Biotech Company for 2014

September 22, 2014
Not Flagship

T2 Biosystems Receives FDA Authorization to Market T2Candida and T2Dx for the Detection of Sepsis-Causing Pathogens

September 22, 2014
Not Flagship

Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration

September 17, 2014
Not Flagship

Joule to Team with DNV GL for Commercial Validation of Transformative CO2-to-Fuels Production Process

September 17, 2014
Not Flagship

Dr. Mark Roskey Joins Quanterix Leadership Team

September 16, 2014
Not Flagship

Seres Health Presents Final Data for Study of SER-109 in Recurrent Clostridium difficile Infection at ICAAC 2014 Conference

September 8, 2014
Not Flagship

Joule and Scatec Solar ASA to Align for Photovoltaic-Powered Solar Fuel Production

September 5, 2014
Not Flagship

CPI Announces Finalists For 2013 Polyurethane Innovation Award

September 5, 2014
Not Flagship

Avedro Acquires Assets of IROC Innocross AG, Including its UV-X Line of Cross-Linking Devices

September 3, 2014
Not Flagship

BIND Therapeutics Appoints Two New Board Members

September 3, 2014
Not Flagship

Oasys Water Continues Growth and Commercialization Momentum in Global Markets

September 2, 2014
Not Flagship

Seres Health to Present Clinical Findings at ICAAC 2014 Conference

August 28, 2014
Not Flagship

Joule to Host Strategic Seminar on Climate Change in Norway, Featuring Jeffrey Sachs

August 28, 2014
Not Flagship

Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration

August 26, 2014
Not Flagship

Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner

August 25, 2014
Is Flagship Story

Joule Achieves Industry First With A 100% Increase In Photosynthetic Efficiency

August 15, 2014
Not Flagship

Eleven Biotherapeutics Reports Second Quarter 2014 Financial Results

August 13, 2014
Not Flagship

Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation

August 13, 2014
Not Flagship

Seventh Sense Biosystems Closes $16 Million Series B Financing

August 13, 2014
Not Flagship

Allergan Acquires LiRIS® Program from TARIS Biomedical®

August 13, 2014
Not Flagship

Acceleron Pharma Reports Second Quarter 2014 Financial Results

August 12, 2014
Not Flagship

Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update

August 12, 2014
Not Flagship

Joule to Present Transformative Climate Change Solution at Arendal Week

August 12, 2014
Not Flagship

T2 Biosystems Announces Pricing of Initial Public Offering

August 7, 2014
Not Flagship

Is this the next big leap for organ transplants?

August 7, 2014
Not Flagship

BIND Therapeutics Reports Second Quarter 2014 Financial Results

August 7, 2014
Not Flagship

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386

July 21, 2014
Not Flagship

Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity

July 16, 2014
Not Flagship

Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data

July 16, 2014
Not Flagship

Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner

July 14, 2014
Is Flagship Story

Acceleron Pharma Appoints Terrence C. Kearney to its Board of Directors

July 14, 2014
Not Flagship

Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499

July 8, 2014
Not Flagship

Seres Health Announces Allowance for Key Patent on the Use of Synergistic Bacterial Compositions

July 7, 2014
Not Flagship

Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido

July 1, 2014
Not Flagship

Joule First to Gain US EPA Clearance for Commercial Use of Modified Cyanobacteria for Fuel Production

July 1, 2014
Not Flagship

Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer

June 24, 2014
Not Flagship

Syros Pharmaceuticals Co-Founders’ Novel Approach to Cancer Regulation Published in Nature

June 23, 2014
Not Flagship

Clinical Chemistry Study Reports on Use of T2MR to Evaluate Hemostasis in Whole Blood

June 23, 2014
Not Flagship

BIND Therapeutics and Roche Collaborate on Discovery of Novel Nanomedicines

June 19, 2014
Not Flagship

Selecta Biosciences to Accelerate Program for Novel Dual Action Vaccine for Malaria

June 17, 2014
Not Flagship

Selecta Biosciences Enters Into Exclusive License Agreement with 3SBio to Develop Drug Candidate to Treat Gout

June 17, 2014
Not Flagship

Selecta Accelerates Immune Tolerance Therapeutics and Announces New Product Candidate, SEL-212, for Refractory and Tophaceous Gout

June 17, 2014
Not Flagship

Moderna Named to CNBC Disruptor 50 List

June 17, 2014
Not Flagship

Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia

June 16, 2014
Not Flagship

Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration

June 13, 2014
Not Flagship

Moderna Announces Expansion to New Facility in Kendall Square

June 12, 2014
Not Flagship

Avedro Becomes Exclusive Global Supplier of MedioCROSS®Riboflavin for Corneal Cross-Linking

June 12, 2014
Not Flagship

Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde to Dual Role as Chief Financial Officer and Chief Product Officer

June 10, 2014
Not Flagship

Kevin Hrusovsky Joins Quanterix as Executive Chairman

June 10, 2014
Not Flagship

Seres Health Closes Series B Financing and Enters into a Research Agreement with Mayo Clinic

June 9, 2014
Not Flagship

Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK Deficiency, a Rare, Hemolytic Anemia

June 9, 2014
Not Flagship

Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis

June 9, 2014
Not Flagship

Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation

June 5, 2014
Is Flagship Story

T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Dx and T2Candida

June 3, 2014
Not Flagship

Seres Health Appoints Former Merck Senior Executive, Roger J. Pomerantz, M.D., F.A.C.P., as Chief Executive Officer and Chairman

June 2, 2014
Not Flagship

Quanterix Selected as a Red Herring Top 100 North America Winner

May 29, 2014
Not Flagship

Novomer Announces Commercial Launch of Converge® Polyols for Broad Use in Polyurethanes Industry

May 29, 2014
Not Flagship

Charles Rowland Elected to BIND Therapeutics Board of Directors

May 28, 2014
Not Flagship

Moderna Forms Technology Advisory Board to Provide Expertise for the Company's GMP Manufacturing Strategy

May 21, 2014
Not Flagship

Joule Names Tom Einar Jensen Head of Corporate Development

May 21, 2014
Not Flagship

Eleven Biotherapeutics Reports Fiscal First Quarter 2014 Financial Results

May 15, 2014
Not Flagship

Joule Achieves ASTM Compliance for Sustainable Diesel, Jet Fuel

May 15, 2014
Not Flagship

Acceleron Pharma Reports First Quarter 2014 Financial Results

May 15, 2014
Not Flagship

Avedro Welcomes Robert J. Palmisano to its Board of Directors

May 14, 2014
Not Flagship

Concert Pharmaceuticals Reports First Quarter 2014 Financial Results

May 14, 2014
Not Flagship

Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer

May 14, 2014
Not Flagship

BG Medicine Reports First Quarter 2014 Financial Results

May 14, 2014
Not Flagship

Receptos Reports First Quarter 2014 Financial Results

May 12, 2014
Not Flagship

Agios Pharmaceuticals Reports First Quarter 2014 Financial Results

May 8, 2014
Not Flagship

BIND Therapeutics Reports First Quarter 2014 Financial Results and Updates BIND-014 Clinical Development Plan

May 8, 2014
Not Flagship

Eleven Biotherapeutics Presents Data on Novel Protein Therapeutics for Treatment of Front and Back of Eye Diseases at ARVO 2014 Annual Meeting

May 6, 2014
Not Flagship

Eleven Biotherapeutics Appoints Gary Sternberg, M.D., M.B.A., as Executive Vice President Corporate and Business Development

May 5, 2014
Not Flagship

Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting

April 28, 2014
Not Flagship

Editas Medicine Co-founders Present Novel Methods for Improving Genome Editing Specificity in Two Nature Biotechnology Papers

April 25, 2014
Not Flagship

Concert Pharmaceuticals Presents Positive 48-Week Results from Phase 2 Clinical Trial of CTP-499 in Diabetic Kidney Disease

April 25, 2014
Not Flagship

Avedro Announces Canadian Approval for its KXL II ™ Advanced Cross-Linking System

April 23, 2014
Not Flagship

Acceleron and Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Patients with End Stage Renal Disease on Hemodialysis

April 23, 2014
Not Flagship

Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for Pyruvate Kinase Deficiency

April 17, 2014
Not Flagship

TransMedics® Announced Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

April 14, 2014
Not Flagship

Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director

April 14, 2014
Not Flagship

Oasys Water Named 2014 Water Technology Company of the Year

April 8, 2014
Not Flagship

Oasys Water Honored as One of Bloomberg’s 2014 New Energy Pioneers at BNEF’s Future of Energy Summit

April 8, 2014
Not Flagship

BIND Therapeutics Presents Clinical Data Highlighting Unique Attributes of Lead Cancer Drug Candidate, BIND-014, at AACR 2014 Annual Meeting

April 7, 2014
Not Flagship

Agios Announces Initial Phase 1 Data Demonstrating Clinical Activity of AG-221, First-in-Class Inhibitor of IDH2 Mutations, in Patients with Advanced Blood Cancers

April 6, 2014
Not Flagship

T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer

April 3, 2014
Not Flagship

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

April 2, 2014
Not Flagship

Concert Pharmaceuticals Reports Year End 2013 Financial Results

March 31, 2014
Not Flagship

BIND Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

March 25, 2014
Not Flagship

Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference

March 25, 2014
Not Flagship

Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes

March 24, 2014
Not Flagship

Agios Enrolls First Patient in Phase 1 Study of AG-120 in Advanced Solid Tumors with an IDH1 Mutation

March 24, 2014
Not Flagship

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy

March 20, 2014
Not Flagship

Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting

March 19, 2014
Not Flagship

Agios Announces Enrollment of First Patient in Phase 1 Study of AG-120 in Advanced Hematologic Malignancies with an IDH1 Mutation

March 19, 2014
Not Flagship

Black Duck Appoints Mark Fusco to its Board of Directors

March 18, 2014
Not Flagship

Concert Pharmaceuticals Appoints Wendell Wierenga to Board of Directors

March 14, 2014
Not Flagship

Quanterix’s Simoa Technology to Detect Blood Biomarker for Concussion in Hockey Players

March 14, 2014
Not Flagship

Tangent Medical Appoints Eric Sandberg to Company President

March 13, 2014
Not Flagship

Flagship Ventures Partner David Berry Named a 2014 Young Global Leader by the World Economic Forum

March 11, 2014
Is Flagship Story

BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers

March 10, 2014
Not Flagship

Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer

March 6, 2014
Not Flagship

Tetraphase Reports Fourth-Quarter and Full-Year 2013 Financial Results

March 6, 2014
Not Flagship

Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

March 6, 2014
Not Flagship

Receptos Reports Fourth Quarter and Year End 2013 Operational and Financial Results

March 5, 2014
Not Flagship

Eleven Biotherapeutics Reports Clinical and Regulatory Updates for EBI-005

March 4, 2014
Not Flagship

Eleven Biotherapeutics Appoints Paul Chaney to Its Board of Directors

March 3, 2014
Not Flagship

BIND Therapeutics Promotes Key Executives: Organization Positioned for Continued Growth

March 3, 2014
Not Flagship

Joule Appoints David Anton Chief Technology Officer

February 28, 2014
Not Flagship

Joule Names Paul Snaith as New President and CEO

February 20, 2014
Not Flagship

Eleven Biotherapeutics Initiates Pivotal Phase 3 Clinical Study with EBI-005 in Dry Eye Disease

February 18, 2014
Not Flagship

Concert Pharmaceuticals Announces Pricing of Initial Public Offering

February 13, 2014
Not Flagship

Pronutria® Announces Launch of Two Clinical Trials

February 13, 2014
Not Flagship

Tangent Medical Receives ISO 13485 Certification

February 12, 2014
Not Flagship

Eleven Biotherapeutics Prices Initial Public Offering

February 6, 2014
Not Flagship

Tetraphase Pharmaceuticals Names Craig Thompson Chief Operating Officer

February 4, 2014
Not Flagship

T2 Biosystems Awarded Top Honor as ‘Most Promising Company’ at Personalized Medicine World Conference 2014

January 30, 2014
Not Flagship

Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer

January 23, 2014
Not Flagship

Quanterix Awarded Grant from GE and the NFL’s Head Health Challenge

January 23, 2014
Not Flagship

Renewable Energy Group Enters Industrial Biotech with Acquisition of LS9

January 22, 2014
Not Flagship

Oasys Water Expands to Support Commercialization and Manufacturing of Industry-Pioneering Forward Osmosis Systems

January 15, 2014
Not Flagship

Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment

January 14, 2014
Not Flagship

Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics(TM) for Rare Diseases

January 13, 2014
Not Flagship

Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile

January 13, 2014
Not Flagship

T2 Biosystems and Collaborators Announce Discovery of Novel Clot Structure Biology Enabled by T2HemoStat

January 9, 2014
Not Flagship

Selventa Receives Patent for Extracting Knowledge From Biological Networks

January 7, 2014
Not Flagship

Blend Therapeutics Appoints Richard Wooster, Ph.D., as Chief Scientific Officer

January 6, 2014
Not Flagship

Eleven Biotherapeutics Adds Biotech Industry Veterans to Management Team and Board

January 2, 2014
Not Flagship

Eleven Biotherapeutics Files Registration Statement for Proposed Initial Public Offering

January 2, 2014
Not Flagship

Eleven Biotherapeutics Establishes Scientific Advisory Board to Guide Ophthalmic Pipeline and Technology Development

December 23, 2013
Not Flagship

Acceleron Earns $7 Million Milestone Payment for Celgene's Initiation of Sotatercept Phase 2 Clinical Trial in Patients with End Stage Renal Disease on Hemodialysis

December 18, 2013
Not Flagship

Syros Pharmaceuticals Announces Publication of Important Scientific Studies Related to Company's Industry-Leading Gene Control Platform

December 18, 2013
Not Flagship

Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors

December 17, 2013
Not Flagship